N-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methyl)-3,4,6-trimethylthieno[2,3-b]pyridine-2-carboxamide

ID: ALA4467950

PubChem CID: 41358726

Max Phase: Preclinical

Molecular Formula: C20H20N2O3S

Molecular Weight: 368.46

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(C)c2c(C)c(C(=O)NCc3ccc4c(c3)OCCO4)sc2n1

Standard InChI:  InChI=1S/C20H20N2O3S/c1-11-8-12(2)22-20-17(11)13(3)18(26-20)19(23)21-10-14-4-5-15-16(9-14)25-7-6-24-15/h4-5,8-9H,6-7,10H2,1-3H3,(H,21,23)

Standard InChI Key:  MNPAUPZTLSHYKE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    1.7527   -9.5256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7515  -10.3451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4596  -10.7541    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4578   -9.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4553   -8.2996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1664   -9.5220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1666  -10.3452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9496  -10.5994    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.4333   -9.9332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9492   -9.2675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2505   -9.9329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6594  -10.6405    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6589   -9.2251    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4765  -10.6402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0435  -10.7532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8854  -11.3478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4741  -12.0528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8823  -12.7599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6980  -11.3431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2015   -8.4902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1081  -12.0420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7047  -12.7586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1213  -13.4625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9431  -13.4558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3465  -12.7392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9282  -12.0292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  7  2  0
  6  4  2  0
  4  1  1  0
  4  5  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10  6  1  0
  9 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
  2 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 22  2  0
 21 19  2  0
 19 16  1  0
 10 20  1  0
 21 22  1  0
 21 26  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
M  END

Associated Targets(Human)

CYP3A4 Tclin Cytochrome P450 (380 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM4 Tclin Muscarinic acetylcholine receptor M4 (6041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 368.46Molecular Weight (Monoisotopic): 368.1195AlogP: 3.92#Rotatable Bonds: 3
Polar Surface Area: 60.45Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.00CX LogP: 3.60CX LogD: 3.60
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.76Np Likeness Score: -1.79

References

1. Poslusney MS, Salovich JM, Wood MR, Melancon BJ, Bollinger KA, Luscombe VB, Rodriguez AL, Engers DW, Bridges TM, Niswender CM, Conn PJ, Lindsley CW..  (2019)  Novel M4 positive allosteric modulators derived from questioning the role and impact of a presumed intramolecular hydrogen-bonding motif in β-amino carboxamide-harboring ligands.,  29  (3): [PMID:30580918] [10.1016/j.bmcl.2018.12.039]

Source